Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice.
From the launch
TareBio develops personalized or population-level vaccines for any disease in weeks. TareBio: YC Summer 2026: TareBio: Vaccines for any cancer or infection in weeks
